Vanderbilt Television News Archive

× Try our new beta.tvnews.vanderbilt.edu website, for new pricing, more content, and immediate delivery of loans.
Search the Archive

Life Line (Targeted Cancer Treatment) #701467

NBC Evening News for Monday, May 13, 2002
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

(Studio: Tom Brokaw) Report introduced.

(New York: Robert Bazell) The use of new cancer drugs designed to target processes inside cancer cells examined. [Cancer patient Zinia SECO - says her new drug does not have bad side effects.] [Memorial Sloan Kettering Cancer Center Dr. Clifford HUDIS - says the drugs target cancer cells and spare normal ones.] [Memorial Sloan Kettering Cancer Center Dr. Howard SCHER - says treatments for cancer are more targeted and less random.]

Reporter(s):
Bazell, Robert;
Brokaw, Tom
Duration:
00:02:10

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.